Home › Lymphoma › Missouri › St. Louis
Pag-aaral pangklinika para sa Lymphoma sa St. Louis, MO
Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa St. Louis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Nagre-recruitPhase 2
- Washington University School of Medicine in St. Louis, St Louis
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- Washington University School of Medicine - Oncology Hospital - Public, St Louis
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Nagre-recruitPhase 1/2
- Washington University School of Medicine in St. Louis, St Louis
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at West County Hospital, Creve Coeur · 12 mi ang layo
Collection of Tissue Samples for Cancer Research
Nagre-recruitObservasyonal na pag-aaral
- Washington University - St. Louis, St Louis
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Nagre-recruitPhase 1/2
- Washington University School of Medicine, St Louis
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Nagre-recruitPhase 1
- Washington University School of Medicine/Siteman Cancer Center, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
Nagre-recruitPhase 2
- Washington University, St. Louis, St Louis
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
Nagre-recruit
- Washington University School of Medicine, St Louis
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Nagre-recruitObservasyonal na pag-aaral
- Washington University School of Medicine, St Louis
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
Nagre-recruitPhase 3
- Saint Louis University, St Louis
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Nagre-recruitPhase 2
- Washington University, St Louis
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- OSF Saint Anthony's Health Center, Alton · 18 mi ang layo
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Nagre-recruitPhase 1/2
- Washington University, St Louis
Pag-aaral para sa Lymphoma sa ibang lungsod
- Houston, TX34 pag-aaral
- Boston, MA33 pag-aaral
- New York City, NY33 pag-aaral
- Washington, DC23 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Chicago, IL20 pag-aaral
- Durham, NC17 pag-aaral
- Philadelphia, PA15 pag-aaral
- Cleveland, OH14 pag-aaral
- Edison, NJ12 pag-aaral
- Atlanta, GA12 pag-aaral
- Seattle, WA12 pag-aaral
Iba pang pag-aaral sa St. Louis
- Non-Small Cell Lung Cancer73 pag-aaral
- Kanser sa Suso64 pag-aaral
- Metastatic Cancer54 pag-aaral
- Colorectal Cancer50 pag-aaral
- Kanser (lahat ng uri)46 pag-aaral
- Kanser sa Prostate46 pag-aaral
- Kanser sa Baga39 pag-aaral
- Kanser sa Ovary38 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Kanser ng Endometrium29 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg28 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.